Alzex Neuropharma

Alzex Neuropharma EBITDA per Share

The EBITDA per Share of Alzex Neuropharma (TRRI) as of Oct 24, 2026 is -0.11 USD. In the previous year, EBITDA per Share was -0.02 USD — a change of 604.39% (lower).

EBITDA per Share

-0.11USD

YoY

604.39%

Last updated:

EBITDA per Share of Alzex Neuropharma is 2022 -0.11 USD. EBITDA per Share of Alzex Neuropharma was 2021 -0.02 USD. It decreases by 604.39% lower compared to the previous year.

The Alzex Neuropharma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.02 USD
Jan 1, 2022
-0.11 USD
The Alzex Neuropharma EBITDA per Share history
YEAREBITDA per ShareYoY
-0.11USD+604.39%
-0.02USD+673.67%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Alzex Neuropharma Stock analysis

What does Alzex Neuropharma do? Alzex Neuropharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alzex Neuropharma stock

EBITDA per Share of Alzex Neuropharma is -0.11 USD in 2022.

EBITDA per Share of Alzex Neuropharma changed from -0.02 USD to -0.11 USD, representing a 604.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Alzex Neuropharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Alzex Neuropharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Alzex Neuropharma